June 9, 2017
##EMAIL##, you've received this email because you're a
valued customer of IsoTech Design.

##EMAIL##, vous recevez ce courriel parce ce que vous êtes un précieux client d'IsoTech Design.
Archive
Home   About Us   News & Articles   Contact Us   Text Version   Subscribe   Unsubscribe
Accueil   À propos de nous   Nouvelles et Actualités   Contactez-nous   Version écrite   S'abonner   Se désabonner
Five Pharmacy Regulations Health Execs Must Keep On Their Radars in 2017
Managed Healthcare Executive
With the first couple of months of 2017 behind them, many in the healthcare industry remain uncertain as to what regulatory challenges they may face as the year unfolds. The debut of the American Health Care Act, proposed by House Republicans on March 6 to replace the Affordable Care Act (ACA), has some optimistic about new reimbursement rates, others bracing for potential regulatory whiplash, and many more just waiting to see what might be passed into law, and when.  READ MORE


USP <800> Delivers Standardization
Pharmacy Purchasing & Products
Historically, the approach to hazardous drug (HD) issues has varied greatly among regulatory bodies. Some state boards took an aggressive stance pursuant to HD compliance, while others demonstrated less interest. Given this, among the more strident benefits of USP <800> Hazardous Drugs — Safe Handing in Healthcare Settings is that it establishes a single, clear standard, to which health systems nationwide will be accountable.  READ MORE


USP <800>: Compliance or complacency?
Pharmacy Practice News
2018 deadline may seem far off, but now is time to prepare, experts say. Hospitals that have invested heavily to bring their sterile compounding facilities into compliance with U.S. Pharmacopeial Convention (USP) General Chapter <797> should be in relatively good shape to meet the more far-reaching demands of USP Chapter <800> for protecting workers against the dangers of hazardous drug exposure. Others still grappling with <797> may face a tougher challenge—even with the deadline for complying with the federally enforceable chapter more than two years away.  READ MORE


Presentation: Important Updates in USP <797> and USP <823>
APhA
Presentation goals
  1. Describe U.S. Pharmacopeia (USP) General Chapter <1823> and discuss updates in the draft USP <823>.
  2. Discuss proposed USP standards and U.S. Food and Drug Administration draft guidance that affect the dispensing of radiopharmaceuticals.
  3. Explain the role that the National Association of Nuclear Pharmacies has taken in nuclear pharmacy topics.
 READ MORE


Practices Rush to Prepare for USP <800>
OncLive
The approval of USP 800 requires sites to “maintain a list of hazardous drugs, which must include any items on the current NIOSH list that the entity handles. The entity’s list must be reviewed at least every 12 months”.[1] Section 2 of the chapter references the National Institute for Occupational Safety and Health (NIOSH) document “NIOSH list of antineoplastic and other hazardous drugs in healthcare settings”, as the resource and starting point for facilities. The latest version of the NIOSH list was published in 2016 and will be updated approximately every 2 years.  READ MORE


On the Road to USP 800; Where Are You?
High-Profile
Pharmacies around the country are in various stages of planning and implementing facility and operational changes to meet the requirements of USP 800 by July 1, 2018. The mile markers are slipping by, but wherever you are on the road to compliance, it’s not too late to consider your options.  READ MORE







IsoTech Design eNews/Infolettre

IsoTech Design Inc.
1320 Graham Blvd, #120
Montreal, QC.
H3P 3C8
800-476-2010
info@isotechdesign.com

To unsubscribe, click here.
Pour vous désabonner, cliquez ici.

Did someone forward this edition to you?
Subscribe here -- it's free!

Est-ce que quelqu'un vous a transféré cette infolettre?
Abonnez-vous ici -- C'est gratuit!
PROTECTING LIFE.
PROTÉGER LA VIE.
PROTEGIENDO LA VIDA.